Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study.
about
SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-GuérinNovel Simulation Model of Non-Muscle Invasive Bladder Cancer: A Platform for a Virtual Randomized Trial of Conservative Therapy vs. Cystectomy in BCG Refractory Patients.Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review.Intravesical therapies for bladder cancer - indications and limitations.Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.Intravesical gemcitabine in combination with mitomycin C as salvage treatment in recurrent non-muscle-invasive bladder cancer.
P2860
Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Activity of endovesical gemcit ...... tients: a translational study.
@ast
Activity of endovesical gemcit ...... tients: a translational study.
@en
type
label
Activity of endovesical gemcit ...... tients: a translational study.
@ast
Activity of endovesical gemcit ...... tients: a translational study.
@en
prefLabel
Activity of endovesical gemcit ...... tients: a translational study.
@ast
Activity of endovesical gemcit ...... tients: a translational study.
@en
P2093
P2860
P356
P1476
Activity of endovesical gemcit ...... tients: a translational study.
@en
P2093
E Bercovich
E Pasquini
G L Frassineti
G L Pappagallo
M Ballardini
N Giovannini
R Silvestrini
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604074
P407
P577
2007-11-06T00:00:00Z